These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12403559)

  • 1. Cognitive deficits in neurofibromatosis 1.
    North K; Hyman S; Barton B
    J Child Neurol; 2002 Aug; 17(8):605-12; discussion 627-9, 646-51. PubMed ID: 12403559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and cellular mechanisms underlying the cognitive deficits associated with neurofibromatosis 1.
    Costa RM; Silva AJ
    J Child Neurol; 2002 Aug; 17(8):622-6; discussion 627-9, 646-51. PubMed ID: 12403561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.
    Hyman SL; Shores A; North KN
    Neurology; 2005 Oct; 65(7):1037-44. PubMed ID: 16217056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofibromatosis type 1: the cognitive phenotype.
    Hofman KJ; Harris EL; Bryan RN; Denckla MB
    J Pediatr; 1994 Apr; 124(4):S1-8. PubMed ID: 8151460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Learning disorders in neurofibromatosis type 1].
    Garcia-Penas JJ
    Rev Neurol; 2017 Feb; 64(s01):S59-S63. PubMed ID: 28256688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific neurocognitive deficits in Cornelia de Lange syndrome.
    Stefanatos GA; Musikoff H
    J Dev Behav Pediatr; 1994 Feb; 15(1):39-43. PubMed ID: 8195434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Von Recklinghausen-neurofibromatosis: a study of the psychological profile.
    Spaepen A; Borghgraef M; Fryns JP
    Birth Defects Orig Artic Ser; 1992; 28(1):85-91. PubMed ID: 1340240
    [No Abstract]   [Full Text] [Related]  

  • 8. Behavioral and cognitive outcomes for clinical trials in children with neurofibromatosis type 1.
    van der Vaart T; Rietman AB; Plasschaert E; Legius E; Elgersma Y; Moll HA;
    Neurology; 2016 Jan; 86(2):154-60. PubMed ID: 26519538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofibromatosis type 1 in childhood: a study of the neuropsychological profile in 45 children.
    Legius E; Descheemaeker MJ; Spaepen A; Casaer P; Fryns JP
    Genet Couns; 1994; 5(1):51-60. PubMed ID: 8031536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The adverse influence of attention-deficit disorder with or without hyperactivity on cognition in neurofibromatosis type 1.
    Lidzba K; Granström S; Lindenau J; Mautner VF
    Dev Med Child Neurol; 2012 Oct; 54(10):892-7. PubMed ID: 22881119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Learning disability subtypes in children with neurofibromatosis.
    Brewer VR; Moore BD; Hiscock M
    J Learn Disabil; 1997; 30(5):521-33. PubMed ID: 9293234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive features that distinguish preschool-age children with neurofibromatosis type 1 from their peers: a matched case-control study.
    Lorenzo J; Barton B; Arnold SS; North KN
    J Pediatr; 2013 Nov; 163(5):1479-83.e1. PubMed ID: 23910685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive function and academic performance in children with neurofibromatosis type 1.
    North K; Joy P; Yuille D; Cocks N; Hutchins P
    Dev Med Child Neurol; 1995 May; 37(5):427-36. PubMed ID: 7768342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioural, academic and neuropsychological profile of normally gifted Neurofibromatosis type 1 children.
    Descheemaeker MJ; Ghesquière P; Symons H; Fryns JP; Legius E
    J Intellect Disabil Res; 2005 Jan; 49(Pt 1):33-46. PubMed ID: 15634310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological evaluation and parental assessment of behavioral and motor difficulties in children with neurofibromatosis type 1.
    Coutinho V; Kemlin I; Dorison N; Billette de Villemeur T; Rodriguez D; Dellatolas G
    Res Dev Disabil; 2016 Jan; 48():220-30. PubMed ID: 26625207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Children and adolescents with neurofibromatosis 1: a behavioral phenotype.
    Dilts CV; Carey JC; Kircher JC; Hoffman RO; Creel D; Ward K; Clark E; Leonard CO
    J Dev Behav Pediatr; 1996 Aug; 17(4):229-39. PubMed ID: 8856518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological function in Tourette syndrome.
    Como PG
    Adv Neurol; 2001; 85():103-11. PubMed ID: 11530420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of the WISC-R full scale IQ from the SFTAA.
    Wikoff RL; Parolini RJ
    J Clin Psychol; 1982 Apr; 38(2):387-8. PubMed ID: 7068878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group.
    Descheemaeker MJ; Plasschaert E; Frijns JP; Legius E
    J Intellect Disabil Res; 2013 Sep; 57(9):874-86. PubMed ID: 23095048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Late sequelae of CNS recurrence of acute lymphoblastic leukemia in childhood].
    Steinberg S; Hartmann R; Wisniewski S; Berger K; Beck JD; Henze G
    Klin Padiatr; 1998; 210(4):200-6. PubMed ID: 9743953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.